Immunocore Holdings plc
IMCR
$37.88
$1.714.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 98.28% | -305.06% | 121.13% | -372.10% | 175.21% |
| Total Depreciation and Amortization | 2.31% | -8.67% | -26.76% | 12.66% | 4.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -142.90% | 303.51% | -87.17% | 353.90% | -196.87% |
| Change in Net Operating Assets | -104.95% | 451.33% | 7.74% | -145.79% | -33.83% |
| Cash from Operations | -117.16% | 5,868.74% | 103.12% | -166.03% | -9.99% |
| Capital Expenditure | -80.68% | -38.93% | 91.69% | -332.85% | -150.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 120.00% | -400.00% | -- | -- | 100.00% |
| Cash from Investing | 117.27% | -413.48% | 374.07% | -327.54% | 99.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -49.16% | 43.87% | 363.82% | 177.78% | -33.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -49.16% | 43.87% | 104.95% | -26,115.66% | 124.21% |
| Foreign Exchange rate Adjustments | -34.13% | 40.85% | 164.65% | -206.10% | 7,826.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.48% | -47.49% | 125.74% | -350.25% | 110.00% |